CRESCENT BIOPHARMA INC.

Historical 13F Holders

Symbol
CBIO
CUSIP
38000Q201
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 38000Q201 since 12/18/2024, largest first.

Filer % of Class Filed
1Globe Capital LLC 13G/A
10.3% 10/14/2025
Event 10/7/2025
Balyasny Asset Management L.P. 13G/A
6.0% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
FMR LLC 13G
Amended under CUSIP G2545C104 on 2/5/2026
10.2% 7/8/2025
Event 6/30/2025
Venrock Healthcare Capital Partners III, L.P. 13G
Amended under CUSIP G2545C104 on 2/17/2026
9.9% 6/23/2025
Event 6/13/2025
Adage Capital Management, L.P. 13D/A
0.4% 6/20/2025
Event 6/20/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 2 473 k $8.51 M
2026 Q1 3 836 k $15.4 M
2025 Q4 2 374 k $161 k